DK0621786T3 - Induceret tolerance over for xenotransplantater - Google Patents

Induceret tolerance over for xenotransplantater

Info

Publication number
DK0621786T3
DK0621786T3 DK93903046T DK93903046T DK0621786T3 DK 0621786 T3 DK0621786 T3 DK 0621786T3 DK 93903046 T DK93903046 T DK 93903046T DK 93903046 T DK93903046 T DK 93903046T DK 0621786 T3 DK0621786 T3 DK 0621786T3
Authority
DK
Denmark
Prior art keywords
recipient
organ
cells
injected
xenograft
Prior art date
Application number
DK93903046T
Other languages
English (en)
Inventor
David H Sachs
A Benedict Cosimi
Megan Sykes
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of DK0621786T3 publication Critical patent/DK0621786T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Optics & Photonics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93903046T 1992-01-08 1993-01-07 Induceret tolerance over for xenotransplantater DK0621786T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81776192A 1992-01-08 1992-01-08
US83859592A 1992-02-19 1992-02-19
PCT/US1993/000184 WO1993013785A1 (en) 1992-01-08 1993-01-07 Induced tolerance to xenografts

Publications (1)

Publication Number Publication Date
DK0621786T3 true DK0621786T3 (da) 2002-04-29

Family

ID=27124202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93903046T DK0621786T3 (da) 1992-01-08 1993-01-07 Induceret tolerance over for xenotransplantater

Country Status (11)

Country Link
US (1) US6296846B1 (da)
EP (1) EP0621786B1 (da)
JP (1) JPH07503012A (da)
AT (1) ATE215375T1 (da)
AU (3) AU679437B2 (da)
CA (1) CA2126094A1 (da)
DE (1) DE69331778T2 (da)
DK (1) DK0621786T3 (da)
ES (1) ES2172514T3 (da)
PT (1) PT621786E (da)
WO (1) WO1993013785A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010033840A1 (en) * 1994-04-25 2001-10-25 Trustees Of Dartmouth College Methods for inducing T cell tolerance to a tissue or organ graft
US6006752A (en) 1996-05-09 1999-12-28 The General Hospital Corporation Mixed chimerism and tolerance
WO1998052582A2 (en) * 1997-05-23 1998-11-26 Hadasit Medical Research Services And Development Ltd. Non-myeloablative tolerogenic treatment
US6447767B1 (en) 1997-05-23 2002-09-10 Hadasit Medical Research Services And Development Ltd. Non-myeloablative tolerogenic treatment
US6428782B1 (en) 1997-05-23 2002-08-06 Hadasit Medical Research Services And Development Ltd. Non-myeloablative tolerogenic treatment
ATE439137T1 (de) * 1997-11-14 2009-08-15 Gen Hospital Corp Behandlung von hämatologischen störungen
WO1999039726A1 (en) 1998-02-04 1999-08-12 The General Hospital Corporation Costimulatory blockade and mixed chimerism in transplantation
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20040259803A1 (en) * 1999-04-15 2004-12-23 Monash University Disease prevention by reactivation of the thymus
US20050020524A1 (en) * 1999-04-15 2005-01-27 Monash University Hematopoietic stem cell gene therapy
US20040241842A1 (en) * 1999-04-15 2004-12-02 Monash University Stimulation of thymus for vaccination development
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
US20070274946A1 (en) * 1999-04-15 2007-11-29 Norwood Immunoloty, Ltd. Tolerance to Graft Prior to Thymic Reactivation
US20040265285A1 (en) * 1999-04-15 2004-12-30 Monash University Normalization of defective T cell responsiveness through manipulation of thymic regeneration
US20060088512A1 (en) * 2001-10-15 2006-04-27 Monash University Treatment of T cell disorders
IL159270A0 (en) * 2001-06-14 2004-06-01 Yissum Res Dev Co Non-myeloablative tolerogenic treatment with tyrphostins
US7258839B2 (en) * 2001-12-21 2007-08-21 Cytonome, Inc. Temperature controlled microfabricated two-pin liquid sample dispensing system
AU2003235652A1 (en) * 2002-01-15 2003-07-30 Advanced Cell Technology, Inc. Cloning b and t lymphocytes
US20080279812A1 (en) * 2003-12-05 2008-11-13 Norwood Immunology, Ltd. Disease Prevention and Vaccination Prior to Thymic Reactivation
DK1799236T3 (da) * 2004-09-10 2012-09-03 Cognate Therapeutics Inc Leverstromaceller til forebyggelse og behandling af immunresponser ved transplantation
CA2597757C (en) 2005-02-10 2016-06-28 Regents Of The University Of Minnesota Vascular/lymphatic endothelial cells
US20070113297A1 (en) * 2005-09-13 2007-05-17 Yongguang Yang Methods and compositions for inhibition of immune responses
CA2969847A1 (en) 2014-12-10 2016-06-16 Regents Of The University Of Minnesota Genetically modified cells, tissues, and organs for treating disease
US11819520B2 (en) 2018-02-23 2023-11-21 Duke University Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772552A (en) 1984-04-23 1988-09-20 Dana-Farber Cancer Institute, Inc. Monoclonal antibody which recognizes a 200-220 KD antigen on natural killer cells
US5160490A (en) * 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition

Also Published As

Publication number Publication date
WO1993013785A1 (en) 1993-07-22
AU3017000A (en) 2000-06-29
AU3989597A (en) 1998-01-08
DE69331778D1 (de) 2002-05-08
US6296846B1 (en) 2001-10-02
EP0621786A1 (en) 1994-11-02
EP0621786B1 (en) 2002-04-03
CA2126094A1 (en) 1993-07-22
ATE215375T1 (de) 2002-04-15
AU679437B2 (en) 1997-07-03
ES2172514T3 (es) 2002-10-01
AU3440093A (en) 1993-08-03
PT621786E (pt) 2002-07-31
DE69331778T2 (de) 2002-11-14
EP0621786A4 (en) 1994-12-14
AU759994B2 (en) 2003-05-01
JPH07503012A (ja) 1995-03-30

Similar Documents

Publication Publication Date Title
DK0621786T3 (da) Induceret tolerance over for xenotransplantater
Kuss et al. Homologous human kidney transplantation: experience with six patients
Lance The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives.
Starzl et al. Transplantation tolerance from a historical perspective
Bonavita et al. Hepatocyte xenotransplantation for treating liver disease
Pierce et al. Prolonged survival of a renal homograft in a dog treated with 6-mercaptopurine
Wells Jr et al. TRANSPLANTATION OF THE PARATHYROID GLANDS IN DOGS Biochemical, Histological, and Radioimmunoassay Proof of Function
Charlemagne Thymus independent anti-horse erythrocyte antibody response and suppressor T cells in the Mexican axolotl (Amphibia, Urodela, ambystoma mexicanum).
Ye et al. Secondary organ allografting after a primary “bridging” xenotransplant
DK0786255T3 (da) Fremgangsmåde til forbedring af tolerancen for allotransplantater og xenotransplantater ved administration af et LFA-3- eller CD2-bindingsprotein
Morton et al. Role of bone marrow transplantation in 90Y antibody therapy of colon cancer xenografts in nude mice
HUME et al. Modification of renal homograft rejection by irradiation
Ross et al. Parathyroid transplantation: fate of a long-term allograft in man
Raaf et al. Fresh and cultured thyroid gland: survival and function after implantation.
Stein-Werblowsky On the latency of tumour cells.
Svehag et al. Synergism between alloantibodies or F (ab') 2 and prednisone in the survival of murine split heart allografts
Banks et al. Effects of intermittent irradiation in situ on renal homotransplantation
ROGERS et al. A review of the conference on the relation of immunology to tissue homotransplantation
Myburgh et al. HEPATIC ALLOTRANSPLANTATION IN THE BABOON: III. The Effects of Immunosuppression and Administration of Donor-Specific Antigen After Transplantation
NAKAMURA et al. Human renal allotransplantation and thymectomy
Kölsch et al. Low numbers of tumor cells suppress the host immune system
Smit et al. Suppressor cell activity following total lymphoid irradiation (TLI), bone marrow (BM) injection, and kidney transplantation in baboons
Vogelfanger et al. Naturally occurring immunosuppressive agents II. The ability of cell-free liver extracts to modify the rejection of allogeneic skin grafts in the rabbit
Calne Biological factors in tissue transplantation
Starzl et al. Antilymphocyte globulins-clinical use